Trial · NCT00514020
Adverse events59
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 59
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | albumin, serum-low | Metabolism and nutrition disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 17 | 24 | 29 |
| other | alkaline phosphatase | Investigations | Oxaliplatin + Leucovorin + 5-Fluorouracil | 10 | 24 | 13 |
| other | ALT/SGPT (serum glutamine pyruvic transminase) | Investigations | Oxaliplatin + Leucovorin + 5-Fluorouracil | 11 | 24 | 15 |
| other | anorexia | Metabolism and nutrition disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 8 | 24 | 8 |
| other | ascites (non-malignant) | Gastrointestinal disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 3 | 24 | 4 |
| other | AST, SGOT (serum glutamine oxaloacetic transminase) | Investigations | Oxaliplatin + Leucovorin + 5-Fluorouracil | 11 | 24 | 13 |
| other | bilirubin (hyperbilirubinemia) | Hepatobiliary disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 2 | 24 | 3 |
| other | calcium, serum-low-hypocalcemia | Metabolism and nutrition disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 10 | 24 | 14 |
| other | constipation | Gastrointestinal disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 7 | 24 | 11 |
| other | creatine | Investigations | Oxaliplatin + Leucovorin + 5-Fluorouracil | 2 | 24 | 3 |
| other | dermatology/skin-other | Skin and subcutaneous tissue disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 2 | 24 | 3 |
| other | diarrhea | Gastrointestinal disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 8 | 24 | 14 |
| other | distension/bloating, abdominal | Gastrointestinal disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 6 | 24 | 6 |
| other | dizziness | Nervous system disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 2 | 24 | 2 |
| other | dysphagia | Gastrointestinal disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 3 | 24 | 3 |
| other | edema-limb | Musculoskeletal and connective tissue disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 3 | 24 | 3 |
| other | fatigue | General disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 12 | 24 | 17 |
| other | glucose, serum-high-hyperglycemia | Metabolism and nutrition disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 11 | 24 | 21 |
| other | heartburn/dyspepsia | Gastrointestinal disorders | Oxaliplatin + Leucovorin + 5-Fluorouracil | 2 | 24 | 2 |
| other | hemoglobin | Investigations | Oxaliplatin + Leucovorin + 5-Fluorouracil | 22 | 24 | 33 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00514020/events